Sale of Clinical Trials Company to Private Equity Fund. Represented Seller in $23MM sale. Buyer was a foreign private equity fund. Transaction recognized by The M&A Advisor as Healthcare/Life Sciences Deal of the Year in its 14th annual International M&A Awards.
Sale of Building Supplies Company to Private Equity Fund. Represented Seller in $40MM sale. Part of a larger roll up by PE firm. Transaction had significant EarnOut and Rollover.
Roll-up of commercial fire prevention systems integrators. Represented two different Sellers (for $16MM and $5MM) in a simultaneous acquisition by PE Fund. The Sellers were in different states, and each underwent an F Reorg prior to closing. Each of the Sellers had varied stakes in the roll-up, both in continued involvement and equity participation.
Sale of 3PL (warehouse, trucking, fulfillment) to a strategic investor. Represented Seller in $6MM sale. The transaction included the lease of a 250,000 sq/ft facility, the transfer of 120 employees and the consent of a customer which accounted for over 70% of Seller’s revenue.
Sale of computer and technology consulting company to competitor. Represented Seller in $11MM sale. The transaction required the consent from various governmental agencies, and significant negotiations over the geographic/business scope and duration of the restrictive covenants.
Purchase of a 51% acquisition of a successful pet franchise business. Represented franchise development company in deal valued in excess of $10MM. The transaction hinged on future management of the entity and included $2MM in new financing to fund growth.